张征峥,马翠卿,邓郁青.miR-155参与缺氧诱导的乳腺癌化疗耐药[J].中国肿瘤,2017,26(2):135-139.
miR-155参与缺氧诱导的乳腺癌化疗耐药
MiR-155 Participates in the Breast Cancer Chemoresistance Induced by Hypoxia
投稿时间:2016-05-05  
DOI:10.11735/j.issn.1004-0242.2017.02.A012
中文关键词:  miR-155  缺氧  乳腺癌  化疗耐药  BCRP
英文关键词:miR-155  hypoxia  breast cancer  chemoresistance  BCRP
基金项目:国家自然科学基金面上项目(81071710);河北省高等学校科学技术研究项目(QN2015011)
作者单位
张征峥 河北医科大学免疫教研室/河北省重大疾病的免疫机制及干预重点实验室 
马翠卿 河北医科大学免疫教研室/河北省重大疾病的免疫机制及干预重点实验室 
邓郁青 河北医科大学免疫教研室/河北省重大疾病的免疫机制及干预重点实验室 
摘要点击次数: 1731
全文下载次数: 653
中文摘要:
      摘 要:[目的] 探讨miR-155在缺氧诱导的乳腺癌化疗耐药中的作用。[方法] 以0、50、100、150、200μmol/L不同浓度CoCl2处理4T1细胞,建立缺氧模型。实时定量PCR检测缺氧条件下miR-155的表达与耐药基因BCRP的表达。通过慢病毒载体转染使miR-155过表达,通过caspase 3/9分光光度法探讨miR-155在缺氧环境下乳腺癌化疗耐药中的作用。[结果] 随缺氧程度的增加,miR-155及BCRP基因表达增加,过表达miR-155可抑制阿霉素诱导的4T1细胞的凋亡。[结论] 随着乳腺癌缺氧程度加重,miR-155表达逐渐增加,miR-155表达与乳腺癌化疗耐药相关。
英文摘要:
      Abstract:[Purpose] To investigate the effect of miR-155 on the drug resistance of breast cancer. [Methods] 4T1 cells were treated by 0,50,100,150,200μmol/L CoCl2. Real time quantitative PCR was conducted to detect the expression of miR-155 and BCRP,a drug resistance gene,under hypoxic condition. To further explore the role of miR-155 in chemoresistance,a lentiviral vector carrying miR-155 precursor was transfected into 4T1 cells. Then the caspase 3/9 activity was conducted by spectrophotometric method. [Results] With the increase of hypoxia,the expression of miR-155 and BCRP gene increased. Over expression of miR-155 repress apoptosis induced by doxorubicin.[Conclusion] With the increasing of hypoxia,the expression of miR-155 increases. MiR-155 expression is associated with chemotherapy resistance in breast cancer.
在线阅读   查看全文  查看/发表评论  下载PDF阅读器